Publication: Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
cris.virtual.author-orcid | 0000-0002-0006-7833 | |
cris.virtualsource.author-orcid | 47df8a33-175d-49c2-8a00-6119b3682ac9 | |
datacite.rights | open.access | |
dc.contributor.author | Kohler, Philipp | |
dc.contributor.author | Fulchini, Rosamaria | |
dc.contributor.author | Albrich, Werner C. | |
dc.contributor.author | Egli, Adrian | |
dc.contributor.author | Balmelli, Carlo | |
dc.contributor.author | Harbarth, Stephan | |
dc.contributor.author | Héquet, Delphine | |
dc.contributor.author | Kahlert, Christian R. | |
dc.contributor.author | Kuster, Stefan P. | |
dc.contributor.author | Petignat, Christiane | |
dc.contributor.author | Schlegel, Matthias | |
dc.contributor.author | Kronenberg, Andreas Oskar | |
dc.date.accessioned | 2024-10-08T15:14:59Z | |
dc.date.available | 2024-10-08T15:14:59Z | |
dc.date.issued | 2018 | |
dc.description.abstract | BACKGROUND: We evaluated data from isolates of nursing home (NH) patients sent to the Swiss centre for antibiotic resistance (ANRESIS). We focussed on carbapenem-resistance (CR) among Gram-negative pathogens, extended-spectrum cephalosporin-resistant (ESC-R) Escherichia coli/Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus (MRSA), and glycopeptide-resistant enterococci (GRE). METHODS: NH patient isolates from 01/2007 to 10/2017 were extracted. Temporal trends in resistance were described and risk factors associated with ESC-R and MRSA were assessed. For every administrative subdivision in Switzerland (i.e. canton), we calculated a coverage rate, defined as number of beds of governmentally-supported nursing homes, which sent ≥1 isolate in each 2014, 2015, and 2016, divided by the total number of supported beds. RESULTS: We identified 16'804 samples from 9'940 patients. A majority of samples (12'040; 71.6%) originated from the French/Italian speaking part of Switzerland. ESC-R E. coli increased from 5% (16/299) in 2007 to 22% (191/884) in 2017 (P < 0.01), whereas MRSA decreased from 34% (35/102) to 26% (21/81) (P < 0.01). Provenience from the German (vs. French/Italian) speaking part of Switzerland was associated with decreased risk for ESC-R (OR 0.5, 95% CI 0.4-0.7) and for MRSA (OR 0.1, 95% CI 0.1-0.2). CR among Pseudomonas aeruginosa was 10% (105/1096) and showed an increasing trend over time; CR among Enterobacteriaceae (37/12'423, 0.3%) and GRE (5/1'273, 0.4%) were uncommon. Overall coverage rate was 9% (range 0-58% per canton). There was a significant difference between the French/Italian (median 13%, interquartile range [IQR] 4-43%) and the German speaking cantons (median 0%, IQR 0-5%) (P = 0.02). CONCLUSIONS: ESC-R among E. coli is emerging in Swiss NHs, whereas MRSA show a declining trend over time. A minority of NHs are represented in ANRESIS, with a preponderance of institutions from the French/Italian speaking regions. Efforts should be undertaken to improve resistance surveillance in this high-risk setting. | |
dc.description.numberOfPages | 9 | |
dc.description.sponsorship | Institut für Infektionskrankheiten | |
dc.identifier.doi | 10.7892/boris.125626 | |
dc.identifier.pmid | 30038781 | |
dc.identifier.publisherDOI | 10.1186/s13756-018-0378-1 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/63606 | |
dc.language.iso | en | |
dc.publisher | BioMed Central | |
dc.relation.ispartof | Antimicrobial Resistance and Infection Control | |
dc.relation.issn | 2047-2994 | |
dc.relation.organization | DCD5A442BD12E17DE0405C82790C4DE2 | |
dc.subject.ddc | 500 - Science::570 - Life sciences; biology | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.title | Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017 | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 88 | |
oaire.citation.volume | 7 | |
oairecerif.author.affiliation | Institut für Infektionskrankheiten | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2019-10-23 10:07:48 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 125626 | |
unibe.journal.abbrevTitle | ANTIMICROB RESIST INFECT CONTROL | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- document.pdf
- Size:
- 1003.43 KB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- https://creativecommons.org/licenses/by/4.0
- Content:
- published